Recent advances in cancer genomics mapping has helped to classify breast cancer based on the expression of cellular receptors, which are estrogen receptor (ER), progesterone receptor, and anti-human epidermal growth factor receptor 2 (HER2) [2]. This evidence concerns the gene PGR and breast carcinoma.